NZ242493A - Quinoline derivatives and pharmaceutical compositions - Google Patents
Quinoline derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ242493A NZ242493A NZ242493A NZ24249392A NZ242493A NZ 242493 A NZ242493 A NZ 242493A NZ 242493 A NZ242493 A NZ 242493A NZ 24249392 A NZ24249392 A NZ 24249392A NZ 242493 A NZ242493 A NZ 242493A
- Authority
- NZ
- New Zealand
- Prior art keywords
- ureido
- bis
- chlorophenyl
- methylthio
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69232391A | 1991-04-26 | 1991-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ242493A true NZ242493A (en) | 1994-08-26 |
Family
ID=24780107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ242493A NZ242493A (en) | 1991-04-26 | 1992-04-24 | Quinoline derivatives and pharmaceutical compositions |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0590094A1 (enExample) |
| JP (1) | JPH0776215B2 (enExample) |
| CN (1) | CN1066068A (enExample) |
| AU (1) | AU1879792A (enExample) |
| BR (1) | BR9205939A (enExample) |
| CA (1) | CA2108014A1 (enExample) |
| CZ (1) | CZ395592A3 (enExample) |
| DE (1) | DE9290049U1 (enExample) |
| FI (1) | FI934710A7 (enExample) |
| HU (1) | HUT65748A (enExample) |
| IE (1) | IE921330A1 (enExample) |
| IL (1) | IL101627A0 (enExample) |
| MX (1) | MX9201916A (enExample) |
| NO (1) | NO933837L (enExample) |
| NZ (1) | NZ242493A (enExample) |
| PT (1) | PT100426A (enExample) |
| TW (1) | TW197436B (enExample) |
| WO (1) | WO1992019614A1 (enExample) |
| YU (1) | YU44592A (enExample) |
| ZA (1) | ZA922976B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2125325T3 (es) * | 1992-01-23 | 1999-03-01 | Pfizer | Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos. |
| US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
| US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
| CA2222687A1 (en) * | 1995-05-31 | 1996-12-05 | Masami Muraoka | Novel naphthyridine derivatives |
| NZ335766A (en) * | 1996-11-26 | 2000-11-24 | Sumitomo Pharma | Naphthyridine derivatives and use as acyl-CoA cholesterol acyl transferase(ACAT) inhibitor as treatment of hyperlipidemia |
| US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
| WO1999043659A1 (en) | 1998-02-25 | 1999-09-02 | Sumitomo Pharmaceuticals Co., Ltd. | Pyridone derivatives and process for producing the same |
| KR20070001922A (ko) | 2003-12-12 | 2007-01-04 | 와이어쓰 | 심장혈관질환 치료에 유용한 퀴놀린 |
| CN103601677B (zh) * | 2013-11-19 | 2015-11-18 | 清华大学 | 制备2-烷硫基喹啉衍生物的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
| WO1991004027A1 (en) * | 1989-09-15 | 1991-04-04 | Pfizer Inc. | New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| TW205037B (enExample) * | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd |
-
1992
- 1992-03-16 FI FI934710A patent/FI934710A7/fi unknown
- 1992-03-16 WO PCT/US1992/001801 patent/WO1992019614A1/en not_active Ceased
- 1992-03-16 CA CA002108014A patent/CA2108014A1/en not_active Abandoned
- 1992-03-16 EP EP92923349A patent/EP0590094A1/en not_active Withdrawn
- 1992-03-16 CZ CS923955A patent/CZ395592A3/cs unknown
- 1992-03-16 DE DE9290049U patent/DE9290049U1/de not_active Expired - Lifetime
- 1992-03-16 AU AU18797/92A patent/AU1879792A/en not_active Abandoned
- 1992-03-16 JP JP4510186A patent/JPH0776215B2/ja not_active Expired - Lifetime
- 1992-03-16 BR BR9205939A patent/BR9205939A/pt not_active Application Discontinuation
- 1992-03-16 HU HU9303025A patent/HUT65748A/hu active IP Right Revival
- 1992-03-17 TW TW081102005A patent/TW197436B/zh active
- 1992-03-24 ZA ZA922976A patent/ZA922976B/xx unknown
- 1992-04-16 IL IL101627A patent/IL101627A0/xx unknown
- 1992-04-24 MX MX9201916A patent/MX9201916A/es not_active IP Right Cessation
- 1992-04-24 NZ NZ242493A patent/NZ242493A/en unknown
- 1992-04-24 YU YU44592A patent/YU44592A/sh unknown
- 1992-04-24 IE IE133092A patent/IE921330A1/en not_active Application Discontinuation
- 1992-04-24 PT PT100426A patent/PT100426A/pt not_active Application Discontinuation
- 1992-04-25 CN CN92103010A patent/CN1066068A/zh active Pending
-
1993
- 1993-10-25 NO NO933837A patent/NO933837L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9205939A (pt) | 1994-09-27 |
| FI934710L (fi) | 1993-10-25 |
| PT100426A (pt) | 1993-08-31 |
| CN1066068A (zh) | 1992-11-11 |
| MX9201916A (es) | 1992-11-01 |
| DE9290049U1 (de) | 1994-01-05 |
| HUT65748A (en) | 1994-07-28 |
| HU9303025D0 (en) | 1994-01-28 |
| EP0590094A1 (en) | 1994-04-06 |
| NO933837L (no) | 1993-10-25 |
| TW197436B (enExample) | 1993-01-01 |
| JPH0776215B2 (ja) | 1995-08-16 |
| WO1992019614A1 (en) | 1992-11-12 |
| FI934710A0 (fi) | 1993-10-25 |
| IE921330A1 (en) | 1992-11-04 |
| YU44592A (sh) | 1994-12-28 |
| FI934710A7 (fi) | 1993-10-25 |
| CA2108014A1 (en) | 1992-10-27 |
| AU1879792A (en) | 1992-12-21 |
| ZA922976B (en) | 1993-10-25 |
| JPH06501025A (ja) | 1994-01-27 |
| CZ395592A3 (en) | 1994-02-16 |
| IL101627A0 (en) | 1992-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5596001A (en) | 4-aryl-3-(heteroarylureido)quinoline derivatves | |
| CA2188164C (en) | Benzamide compounds and pharmaceutical use thereof | |
| US5885996A (en) | Antiproliferative quinazolines | |
| RU2256662C2 (ru) | Бициклические азотсодержащие гетероциклы и содержащая их фармацевтическая композиция | |
| EP1254138B1 (en) | Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase | |
| EP1121355B1 (en) | Quinoline derivatives and their use as antibacterial agents | |
| US5063227A (en) | Quinazoline-substituted pyridazinone derivatives having cardiotonic activity | |
| EP0642498A1 (en) | NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT) | |
| US5565472A (en) | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents | |
| CA2128093C (en) | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents | |
| NZ242493A (en) | Quinoline derivatives and pharmaceutical compositions | |
| US4757073A (en) | Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use | |
| CA2179735A1 (en) | N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs | |
| JPS6024794B2 (ja) | オキサジアゾロピリミジン誘導体 | |
| CA2260057A1 (en) | Novel compounds | |
| EP0218423B1 (en) | 9-(Substituted thio)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives, their manufacture and use | |
| WO2003031444A1 (en) | Polycyclic compounds having anti-tumor activity | |
| AU2002342752A1 (en) | Polycyclic compounds having anti-tumor activity | |
| WO1994002469A1 (en) | Pyrimidine compounds used in the therapy | |
| JP2961891B2 (ja) | ベンズアミド化合物およびその医薬用途 | |
| US5484924A (en) | Imidazonaphthyridine derivatives | |
| NZ238434A (en) | Antiasthmatic, antiinflammatory (3h,7h)thiazolo(3,4-a)pyridine derivatives; pharmaceutical compositions and preparatory processes | |
| JPH0259571A (ja) | ピリドン誘導体又はその塩類 | |
| JPWO1995028387A1 (ja) | ベンズアミド化合物およびその医薬用途 |